respiratory benchmarking packs

44
Respiratory Benchmarking Packs South East Coast September 2010

Upload: lan

Post on 22-Jan-2016

24 views

Category:

Documents


0 download

DESCRIPTION

Respiratory Benchmarking Packs. South East Coast September 2010. Respiratory Benchmarking Packs. We have taken two approaches to looking for unwarranted variation in respiratory health care Benchmarking of all South East Coast PCTs against selected indicators - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Respiratory Benchmarking Packs

Respiratory Benchmarking Packs

South East CoastSeptember 2010

Page 2: Respiratory Benchmarking Packs

Respiratory Benchmarking Packs

We have taken two approaches to looking for unwarranted variation in respiratory health care

1.Benchmarking of all South East Coast PCTs against selected indicators

2.Health investment analysis for selected PCTs using programme budgeting tools

Page 3: Respiratory Benchmarking Packs

Purpose of Benchmarking Packs

l The key purpose of the packs is to help engage local commissioners and clinicians in reducing unwarranted variation

l Reducing unwarranted variation will improve outcomes for patients and reduce healthcare costs

Page 4: Respiratory Benchmarking Packs

Unwarranted Variation

l Some variation may be accounted for by local population characteristics, but much is unwarranted and due to the different ways services are organised and delivered. What is achievable for patients in one area should be possible in all areas.

l Unwarranted variation in respiratory healthcare wastes resources and adversely affects an individual’s chance of receiving timely and accurate diagnosis, of being offered appropriate treatment, of requiring emergency admission to hospital and of recovering after an exacerbation.

Page 5: Respiratory Benchmarking Packs

Questions will Generate Answers

l By triangulating data from a number of sources, this analysis draws on a wide evidence base.

l But the main purpose of the benchmarking packs is not to provide answers.

l By highlighting unwarranted variation, the packs can be used to stimulate local dialogue about the quality of care that is commissioned and delivered.

l Their value lies in helping us to formulate robust questions that clinicians and commissioners will want to address.

Page 6: Respiratory Benchmarking Packs

How do our Systems Compare with the Best?

l So where expenditure is relatively high and outcomes relatively poor, where there are high rates of mortality, admission and length of stay compared with socio-demographically similar PCTs…..

l Commissioners and clinicians will want to know whether local providers have similar systems and offer similar services to the best performing providers.

l Your Director of Public Health, Quality Observatory and Public Health Observatory will be able to assist in interpreting the data and framing the questions.

Page 7: Respiratory Benchmarking Packs

Some Questions about Service Quality

1. Is there a local programme of case finding for COPD to ensure early diagnosis, to optimise proactive management and to

minimise risk of expensive hospital admission

2. Do GP practices and community providers offer: quality-assured diagnosis support for self-management quality clinical review in line with NICE guidance appropriate referral for LTOT assessment and pulmonary rehab Appropriate assessment and review of oxygen requirement

3. Do hospitals offer: access to specialist respiratory care early measurement of blood gas status and assessment for NIV optimal management of co-morbid conditions early supported discharge or hospital at home

Page 8: Respiratory Benchmarking Packs

1. Local PCT Benchmarkingfor selected indicators

Analysis by Julian Flowers for ERPHO/APHO

Page 9: Respiratory Benchmarking Packs

Five Measures of Variation

Burden and Detection• Prevalence and gap between observed and expected prevalence

Admission Rates• Per 1000 COPD registered patients

Hospital Utilisation• Emergency bed days/1000 PCT residents,

Quality Indicators• Readmission rates, hospital mortality

Cost • In patient cost per 1000 population

Page 10: Respiratory Benchmarking Packs
Page 11: Respiratory Benchmarking Packs
Page 12: Respiratory Benchmarking Packs
Page 13: Respiratory Benchmarking Packs
Page 14: Respiratory Benchmarking Packs
Page 15: Respiratory Benchmarking Packs
Page 16: Respiratory Benchmarking Packs

2. Health Investment Analysis For Selected PCTs

Commissioning Analysis and Intelligence TeamDepartment of Health

QIPP Right Care

Page 17: Respiratory Benchmarking Packs

QIP

P R

igh

t C

are

17

Health Investment slide packs - Respiratory

The following Health Investment slides use programme budgeting tools to highlight variation in health care at PCT and practice level.

For each SHA region, respiratory slide packs have been produced for selected PCTs where the evidence suggests that there may be significant variation in spend and outcome.

Page 18: Respiratory Benchmarking Packs

QIP

P R

igh

t C

are

Respiratory Health Investment PacksSouth East Coast

The following selected slides illustrate some of the key findings for two PCTs in the South East Coast:

• NHS Eastern and Coastal Kent

• NHS West Kent

The full slide packs for each PCT are available separately.

18

Page 19: Respiratory Benchmarking Packs

NHS Eastern and Coastal Kent Health investment analysis

QIPP Right Care

Page 20: Respiratory Benchmarking Packs

QIP

P R

igh

t C

are

20

Summary

These slides use Programme Budgeting tools to show that

Eastern and Coastal Kent PCT has;

• Increased expenditure on Respiratory problems in the last three years but relatively low inpatient spend

• High Mortality rates from COPD

• Low Prescribing expenditure on Respiratory system problems

• High Prevalence of COPD in QOF

• High Non elective admissions with low spell length of stay

• Large variations in Respiratory admissions at practice level.

Page 21: Respiratory Benchmarking Packs

QIP

P R

igh

t C

are

21

2008/2009 APHO ONS Cluster Average – Each diamond represents a disease category and shows spend and outcomes compared to the ONS Cluster group

Eastern and Coastal Kent PCT has higher than average spend and a worse outcome for Respiratory problems when compared to PCTs within the same cluster.

Mortality from

bronchitis Under 75s

Page 22: Respiratory Benchmarking Packs

QIP

P R

igh

t C

are

22

Years of life lost due to mortality from bronchitis, emphysema and other COPD Directly age-standardised rate per 10,000 population, less than 75 years, all persons 2005-2007 filtered by PCT relevant ONS cluster 2007/2008

Eastern and Coastal Kent PCT has a high rate of years of life lost due to mortality from bronchitis, emphysema and other COPD rate when compared to similar PCTs (Prospering Smaller Towns)

Page 23: Respiratory Benchmarking Packs

QIP

P R

igh

t C

are

23

Years of life lost due to mortality from bronchitis, emphysema and other COPD Directly age-standardised rate per 10,000 population, less than 75 years, all persons 2005-2007 filtered by SHA 2007/2008

Eastern and Coastal Kent PCT high rate of years of life lost due to mortality from bronchitis, emphysema and other COPD rate when compared to PCTs in South East coast SHA

Page 24: Respiratory Benchmarking Packs

QIP

P R

igh

t C

are

24

FHS Prescription expenditure: Respiratory system per 100,000 population (weighted for age, sex and need) FY 2007/8 filtered by PCT relevant ONS cluster 2007/2008

Eastern and Coastal Kent PCT has a low FHS prescription expenditure when compared to PCTs (Prospering Smaller Towns)

Page 25: Respiratory Benchmarking Packs

QIP

P R

igh

t C

are

25

FHS Prescription Volume: Respiratory system per 100,000 population (weighted for age, sex and need) FY 2007/8 filtered by PCT relevant ONS cluster 2007/2008

Eastern and Coastal Kent PCT has a low FHS prescription volume when compared to similar PCTs (Prospering Smaller Towns)

Page 26: Respiratory Benchmarking Packs

QIP

P R

igh

t C

are

26

Prevalence of COPD (QOF); Percent, all ages: FY 2007/8 filtered by PCT relevant ONS cluster 2007/2008

Eastern and Coastal Kent PCT has an above average prevalence of COPD when compared to similar PCTs (Prospering Smaller Towns)

Page 27: Respiratory Benchmarking Packs

QIP

P R

igh

t C

are

27

Prevalence of COPD (QOF); Percent, all ages: FY 2007/8 filtered by SHA 2007/2008

Eastern and Coastal Kent PCT has an above average prevalence of COPD when compared to PCTs in South East coast SHA

Page 28: Respiratory Benchmarking Packs

QIP

P R

igh

t C

are

28

Vaccination against influenza for patients with COPD (QOF) Patients all ages, FY 2007/8 filtered by PCT relevant ONS cluster 2007/2008

Eastern and Coastal Kent PCT has a below average number of vaccinations against Influenza for patients with COPD when compared to similar PCTs (Prospering Smaller Towns)

Page 29: Respiratory Benchmarking Packs

QIP

P R

igh

t C

are

29

Hospitalisation: Respiratory system problems. All Non-elective admissions, indirectly age-standardised rate per 100,000 population, all ages FY 2007/2008 filtered by PCT relevant ONS cluster 2007/2008

Eastern and Coastal Kent PCT has an above average number of Non elective admissions when compared to similar PCTs (Prospering Smaller Towns)

Page 30: Respiratory Benchmarking Packs

QIP

P R

igh

t C

are

30

Spell length of stay: Respiratory system problems. Non-Elective admissions, indirectly age-standardised geometric mean LOS (days) per spell, all ages FY 2007/2008 filtered by PCT relevant ONS cluster 2007/2008

Eastern and Coastal Kent PCT has a low spell length of stay for Non-elective admissions when compared to similar PCTs (Prospering Smaller Towns)

Page 31: Respiratory Benchmarking Packs

QIP

P R

igh

t C

are

31

2009/10 Quarter 1 NHS Comparators – GP Practice Level Comparison of Expenditure on Problems of Respiratory Admissions

Easy to identify high and low spending practices. Can compare practices within groups based on

need of population

2009/10 Quarter 1: Eastern and Coastal Kent PCT has a large variation in Respiratory admissions at practice level.

Page 32: Respiratory Benchmarking Packs

NHS West Kent PCTHealth investment analysis

QIPP Right Care

Page 33: Respiratory Benchmarking Packs

QIP

P R

igh

t C

are

3333

Overview

These slides use Programme Budgeting tools to show that, compared to similar PCTs, West Kent has;

• Average expenditure on Respiratory problems

• High rate of mortality from COPD

• Below average prescription expenditure on Respiratory problems

• High reported prevalence of COPD and a high ratio of reported to expected prevalence of COPD

• Below above average flu vaccinations for patients with COPD

• Spend of £500,000 more than the national average for inpatient admissions for Respiratory problems adjusting for age, sex and need of population

Page 34: Respiratory Benchmarking Packs

QIP

P R

igh

t C

are

34

2008/2009 APHO ONS Cluster Average – Each diamond represents a disease category and shows spend and outcomes compared to the cluster average

West Kent PCT has average spend and worse outcome for Respiratory compared to similar PCTs

Mortality from

bronchitis, emphysema,

COPD

Page 35: Respiratory Benchmarking Packs

QIP

P R

igh

t C

are

35

Mortality from bronchitis, emphysema and other COPD: Directly age-standardised rate per 100,000 population, all ages, all persons 2005-2007

West Kent PCT has the highest mortality rate from bronchitis, emphysema and other COPD when compared to similar PCTs

Page 36: Respiratory Benchmarking Packs

QIP

P R

igh

t C

are

36

Emergency readmission to hospital within 28 days of discharge: Respiratory system. Admissions excluding day cases, indirectly age-standardised percent, all ages. 2007/2008

West Kent PCT has a high rate of emergency readmissions for Respiratory problems when compared to similar PCTs

Page 37: Respiratory Benchmarking Packs

QIP

P R

igh

t C

are

37

Prevalence of COPD (QOF), Percent, all ages, 2007/2008

West Kent PCT has high reported prevalence of COPD compared to similar PCTs

Page 38: Respiratory Benchmarking Packs

QIP

P R

igh

t C

are

38

FHS prescription expenditure: Respiratory system: Thousand pounds per 100,000 unified weighted population, 2007/2008

West Kent PCT has below average FHS prescribing expenditure on Respiratory compared to similar PCTs

Page 39: Respiratory Benchmarking Packs

QIP

P R

igh

t C

are

39

Vaccinations against influenza for patients with COPD (QOF); Percent, all ages, 2007/2008

West Kent PCT has below above average flu vaccinations for patients with COPD compared to similar PCTs

Page 40: Respiratory Benchmarking Packs

QIP

P R

igh

t C

are

40

NHS Comparators – Expenditure on Obstructive Airways Disease emergency admissions – Comparison with similar PCTs

West Kent PCT has high expenditure on Obstructive Airways Disease emergency admissions compared to similar PCTs

Page 41: Respiratory Benchmarking Packs

QIP

P R

igh

t C

are

41

West Kent PCT has a large variation at GP practice level for expenditure on Respiratory emergency admissions

Easy to identify high and low spending practices. Can compare practices within groups based on

need of population

NHS Comparators – Expenditure on Respiratory emergency admissions – GP Practice level

Page 42: Respiratory Benchmarking Packs

QIP

P R

igh

t C

are

42

IVET: PCT inpatient expenditure above or below the benchmark for diseases in 2008-09.

West Kent PCT spend £500,000 more than the national average on Respiratory inpatient admissions adjusting for age, sex and need of population

Page 43: Respiratory Benchmarking Packs

Conclusion

l Benchmarking suggests there is significant unwarranted variation in the respiratory healthcare received by patients in South Central

l What is achievable for patients in one area should be possible in all areas

l By highlighting unwarranted variation, the packs can be used to stimulate local dialogue about the quality of care that is commissioned and delivered.

l Their value lies in helping us to formulate robust questions that clinicians and commissioners will want to address.

Page 44: Respiratory Benchmarking Packs

Conclusion

l Where expenditure is relatively high and outcomes relatively poor, where there are high rates of mortality, admission and length of stay compared with socio-demographically similar PCTs…..

l Commissioners and clinicians will want to know whether local providers have similar systems and offer similar services to the best performing providers.